185
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma

, , , , &
Pages 523-534 | Received 07 Sep 2017, Accepted 29 Oct 2017, Published online: 21 Nov 2017

References

  • Stewart B, Wild CP. World cancer report 2014. Lyon, France: IARC; 2014.
  • Darcy DG, Malek MM, Kobos R, et al. Prognostic factors in fibrolamellar hepatocellular carcinoma in young people. J Pediatr Surg. 2015;50:153–156.
  • Gurtsevitch V. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc). 2008;73:504–513.
  • Chang CK, Astrakianakis G, Thomas DB, et al. Occupational exposure and risks of liver cancer among Shanghai female textile workers – a case cohort study. Int J Epidemiol. 2006;35:361–369.
  • Darvesh AS, Bishayee A. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr Cancer. 2013;65:329–344.
  • Liao N, Sun L, Chen J, et al. A novel polysaccharide conjugate from bullacta exarata induces G1-phase arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Molecules. 2017;22:384.
  • Patel S. Therapeutic importance of sulfated polysaccharides from seaweeds: updating the recent findings. 3 Biotech. 2012;2:171–185.
  • Wu H, Zhu H, Li X, et al. Induction of apoptosis and cell cycle arrest in A549 human lung adenocarcinoma cells by surface-capping selenium nanoparticles: an effect enhanced by polysaccharide-protein complexes from Polyporus rhinocerus. J Agric Food Chem. 2013;61:9859–9866.
  • Matloub AA, Aglan HA, Elsouda SS, et al. Influence of bioactive sulphated polysaccharide-protein complexes on hepatocarcinogenesis, angiogenesis and immunomodulatory activities. Asian Pac J Trop Med. 2016;9:1200–1211.
  • Aburahma MH. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Deliv. 2016;23:1847–1867.
  • Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145–160.
  • Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv. 2009;6:813–825.
  • Bramwell VW, Perrie Y. Particulate delivery systems for vaccines: what can we expect? J Pharm Pharmacol. 2006;58:717–728.
  • Andrieux K, Forte L, Lesieur S, et al. Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt. Eur J Pharm Biopharm. 2009;71:346–355.
  • Chen Y, Lu Y, Chen J, et al. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm. 2009;376:153–160.
  • Niu M, Tan Y, Guan P, et al. Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. Int J Pharm. 2014;460:119–130.
  • Arzani G, Haeri A, Daeihamed M, et al. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Int J Nanomedicine. 2015;10:4797–4813.
  • Guan P, Lu Y, Qi J, et al. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomedicine. 2011;6:965–974.
  • Niu M, Lu Y, Hovgaard L, et al. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Eur J Pharm Biopharm. 2012;81:265–272.
  • Mann JF, Scales HE, Shakir E, et al. Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity. Methods. 2006;38:90–95.
  • Shukla A, Khatri K, Gupta PN, et al. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci. 2008;11:59–66.
  • Shukla A, Singh B, Katare OP. Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes. Br J Pharmacol. 2011;164:820–827.
  • Wilkhu JS, Mcneil SE, Anderson DE, et al. Characterization and optimization of bilosomes for oral vaccine delivery. J Drug Target. 2013;21:291–299.
  • Jain S, Harde H, Indulkar A, et al. Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration. Nanomedicine. 2014;10:431–440.
  • Al-Mahallawi AM, Abdelbary AA, Aburahma MH. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm. 2015;485:329–340.
  • Matloub AA, El-Souda SS, El-Senousy WM, et al. In vitro antiviral, cytotoxic, antioxidant and hypolipidemic activities of polysaccharide isolated from marine algae. Int J Pharm Pharm Res. 2015;7:1099–1111.
  • Dai Y, Zhou R, Liu L, et al. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomed. 2013;8:1921–1933.
  • Albalasmeh AA, Berhe AA, Ghezzehei TA. A new method for rapid determination of carbohydrate and total carbon concentrations using UV spectrophotometry. Carbohydr Polym. 2013;97:253–261.
  • Karimov KHY, Inoyatova FKH, Mukhamedova MT. Changes in some indices of the synthesis of nitric oxide during the early stages of hepatocarcinogenesis. Exp Toxicol Pathol. 2003;55:17–19.
  • Barnes JM, Paget GE. Mechanisms of toxic action. Prog Med Chem. 1965;4:18–38.
  • Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56–63.
  • Wenger C, Kaplan A, Rubaltelli FF, et al. Alkaline phosphatase. Clin Chem. 1984;30:1094–1098.
  • Young DS, Friedman RB. Effects of disease on clinical laboratory tests. 4th ed. Washington (DC): AACC Press; 2001.
  • Banchroft JD, Stevens A, Turner DR. Theory and practice of histological techniques. Philadelphia (PA): Churchill Livingstone; 1996.
  • Rajera R, Nagpal K, Singh SK, et al. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 2011;34:945–953.
  • Pütz G, Schmider W, Nitschke R, et al. Synthesis of phospholipid-conjugated bile salts and interaction of bile salt-coated liposomes with cultured hepatocytes. J Lipid Res. 2005;46:2325–2338.
  • Sun W, Zou W, Huang G, et al. Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target. 2008;16:357–365.
  • Mann JF, Shakir E, Carter KC, et al. Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine. 2009;27:3643–3649.
  • Eldridge JH, Hammond CJ, Meulbroek JA, et al. Controlled vaccine release in the gut-associated lymphoid tissues. 1 Orally administered biodegradable microspheres target the Peyer’s patches. J Control Release. 1990;11:205–214.
  • Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (span 85). Int J Pharm. 1994;105:1–6.
  • Wan LSC, Lee PFS. Studies on surface films of sorbitan-esters at the air/water interface: I. Can J Pharm Sci. 1974a;9:82–85.
  • Wan LSC, Lee PFS. Studies on surface films of sorbitan-esters at the air/water interface: II. Can J Pharm Sci. 1974b;9:85–89.
  • Zeisig R, Shimada K, Hirota S, et al. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim Biophys Acta. 1996;1285:237–245.
  • Shamma RN, Elsayed I. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res. 2013;23:244–254.
  • Abousamra MM, Salama AH. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems. J Liposome Res. 2017;27:324–334.
  • Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces. 2003;30:129–138.
  • Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–111.
  • Conacher M, Alexander J, Brewer JM. Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine. 2001;19:2965–2974.
  • Nightingale CH, Axelson JE, Gibaldi M. Physiologic surfaceactive agents and drug absorption. 8. Effect of bile flow on sulfadiazine absorption in the rat. J Pharm Sci. 1971;60:145–147.
  • Miyazaki S, Yamahira T, Nadai T. Effect of bile flow on indomethacin absorption in rats. Acta Pharm Suec. 1981;18:135–138.
  • Allam A, Fetih G. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate. Drug Des Devel Ther. 2016;10:2421–2433.
  • Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9:740–747.
  • Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm. 2005;300:95–101.
  • Mittal G, Brar A, Soni G. Impact of hypercholesterolemia on toxicity of N-nitrosodiethylamine: biochemical and histopathological effects. Pharmacol Rep. 2006;58:413–419.
  • Bansal AK, Bansal M, Soni G, et al. Modulation of N-nitrosodiethylamine (NDEA) induced oxidative stress by vitamin E in rat erythrocytes. Hum Exp Toxicol. 2005;24:297–302.
  • Verna L, Whysner J, Williams GM. N-Nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther. 1996;71:57–81.
  • Gopalakrishnan R, Sundaram J, Sattu K, et al. Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma. Mol Cell Biochem. 2013;377:163–176.
  • Arul D, Subramanian P. Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Biochem Biophys Res Commun. 2013;434:203–209.
  • Ali F, Rahul F, Naz F, et al. Protective effect of apigenin against N-nitrosodiethylamine (NDEA) induced hepatotoxicity in albino rats. Mutat Res Genet Toxicol Environ Mutagen. 2014;767:13–20.
  • Kujawska M, Ewertowska M, Adamska T, et al. Protective effect of yellow tea extract on N-nitrosodiethylamine-induced liver carcinogenesis. Pharm Biol. 2016;54:1891–1900.
  • Hussein RH, Khalifa FK. The protective role of ellagitannins flavonoids pretreatment against N-nitrosodiethylamine induced-hepatocellular carcinoma. Saudi J Biol Sci. 2014;21:589–596.
  • Vozarova B, Stefan N, Lindsay S, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51:895.
  • Iqbal J, Minhajuddin M, Beg ZH. Suppression of diethylnitrosamine and 2-acetylaminoflurene induced hepatocarcinogenesis in rats by tocotrienol rich fraction isolated from rice bran oil. Eur J Can Prev. 2004;13:515–520.
  • Pancoska P, De Giorgio M, Fagiuoli S, et al. Small HCCs identified by screening. Dig Dis Sci. 2011;56:3078–3085.
  • Rizk MZ, Aly HF, Matloub AA, et al. The anti-hypercholesterolemic effect of Ulvan polysaccharide extracted from the green alga Ulva fasciata on aged hypercholesterolemic rats. Asian J Pharm Clin Res. 2016;9:165–176.
  • Zhang Q, Li N, Zhou G, et al. In vivo antioxidant activity of polysaccharide fraction from Porphyra haitanesis (Rhodephyta) in aging mice. Pharmacol Res. 2003;48:151–155.
  • Qi H, Zhang Q, Zhao T, et al. In vitro antioxidant activity of acetylated and benzoylated derivatives of polysaccharide extracted from Ulva pertusa (Chlorophyta). Bioorg Med Chem Lett. 2006;16:2441–2445.
  • Sathivel A, Balavinayagamani Hanumantha Rao BR, et al. Sulfated polysaccharide isolated from Ulva lactuca attenuates d-galactosamine induced DNA fragmentation and necrosis during liver damage in rats. Pharm Biol. 2014;52:498–505.
  • Besednova NN, Zaporozhets TS, Kuznetsova TA, et al. Hepatoprotective effects of extracts and polysaccharides from seaweed. Antibiot Khimioter. 2014;59:30–37.
  • Wang Z, Xie J, Yang Y, et al. Sulfated Cyclocarya paliurus polysaccharides markedly attenuates inflammation and oxidative damage in lipopolysaccharide-treated macrophage cells and mice. Sci Rep. 2017;7:40402.
  • Rezaie A, Fazlara A, Haghi Karamolah M, et al. Effects of echinacea Purpurea on hepatic and renal toxicity induced by diethylnitrosamine in rats. Jundishapur J Nat Pharm Prod. 2013;8:60–64.
  • Mahmoud AM, Ahmed RR, Soliman HA, et al. Ruta graveolens and its active constituent rutin protect against diethylnitrosamine-induced nephrotoxicity through modulation of oxidative stress. J Appl Pharm Sci. 2015;5:16–21.
  • Lopez-Novoa JM, Bernabeu C. The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol. 2010;299:H959–H974.
  • Adejuwon AA, Adokiye SB. Protective effect of the aqueous leaf and seed extract of Phyllanthus amarus on gentamicin and acetaminophen-induced nephrotoxic rats. J Ethnopharmacol. 2008;118:318–323.
  • Nenad S, Dragan M, Slavimir V. Glomerular basement membrane alterations induced by gentamicin administration in rats. Exp Toxicol Pathol. 2008;60:69–75.
  • Borges LP, Borges VC, Moro AV, et al. Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology. 2005;210:1–8.
  • Afzal M, Kazmi I, Gupta G, et al. Preventive effect of Metformin against N-nitrosodiethylamine-initiated hepatocellular carcinoma in rats. Saudi Pharm J. 2012;20:365–370.
  • Lazarevich NL. Review: molecular mechanisms of alpha-fetoprotein gene expression. Biochemistry (Mosc). 2000;65:117–133.
  • Mohamed RA, Maghraby HM, Abd El Salama EM, et al. Evaluation of serum endoglin as noninvasive marker in hepatocellular carcinoma. Egypt J Intern Med. 2015;27:15–20.
  • Nassiri F, Cusimano MD, Scheithauer BW, et al. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res. 2011;31:2283–2290.
  • Meurer SK, Tihaa L, Borkham-Kamphorst E, et al. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cell Signal. 2011;23:683–699.
  • Talaat M, El-Sayed N, Kandeel A, et al. Sentinel surveillance for patients with acute hepatitis in Egypt, 2001–04. East Mediterr Health J. 2010;16:134–140.
  • Esmat G, Hashem M, El-Raziky M, et al. Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children. Liver Int. 2011;10:1478–3231.
  • Yagmur E, Rizk M, Stanzel S, et al. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma. Eur J Gastroenterol Hepatol. 2007;9:755–761.
  • Heindryckx F, Mertens K, Charette N, et al. Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma. Mol Cancer. 2010;9:219.
  • Asimakopoulou A, Weiskirchen S, Weiskirchen R. Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy. Front Physiol. 2016;7:430.
  • El Moety HA, El Sharkawy RM, El Menem Hussein NA. Lipocalin: a novel diagnostic marker for hepatocellular carcinoma in chronic liver disease patients in Egypt. Int J Clin Med. 2013;4:440–450.
  • Gehrmann M, Cervello M, Montalto G, et al. Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Front Immunol. 2014;5:307.
  • Sakamoto M. Early HCC: diagnosis and molecular markers. J Gastroenterol. 2009;44:108–111.
  • Bayer C, Liebhardt ME, Schmid TE, et al. Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models. Int J Radiat Oncol Biol Phys. 2014;88:694–700.
  • Chuma M, Sakamoto M, Yamazaki K. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology. 2003;37:198–207.
  • Takashima M, Kuramitsu Y, Yokoyama Y. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics. 2003;3:2487–2493.
  • Luk JM, Lam CT, Siu AF. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) upregulation and their associated prognostic values. Proteomics. 2006;6:1049–1057.
  • Wang S, Konorev EA, Kotamraju S, et al. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms intermediacy OF H2O2- AND p53-dependent pathways. J Biol Chem. 2004;279:25535–25543.
  • Denard B, Chen Q, Lee C, et al. The anti-proliferative effect of doxorubicin is catalyzed through the proteolytic activation of CREB3L1. FASEB J. 2015;29:576.3.
  • Fedorov SN, Ermakova SP, Zvyagintseva TN, et al. Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects. Mar Drugs. 2013;11:4876–4901.
  • Itoh H, Noda H, Amano H, et al. Antitumor activity and immunological properties of marine algal polysaccharides, especially fucoidan, prepared from Sargassum thunbergii of Phaeophceae. Anticancer Res. 1993;13:2045–2052.
  • Ren DL, Wang JZ, Noda H, et al. The effects of an algal polysaccharide from Gloiopeltis tenax on transplantable tumors and immune activities in mice. Planta Med. 1995;61:120–125.
  • Arican G, Arican E. Evaluation of the apoptotic and antiproliferative activities of paclitaxel in Ehrlish ascites tumor cells. Biotechnol Biotechnol Eq. 2006;20:69–75.
  • Salama AH, Aburahma MH. Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging. Pharm Dev Technol. 2016;21:706–715.
  • Rajan B, Ravikumar R, Premkumar T, et al. Carvacrol attenuates N-nitrosodiethylamine induced liver injury in experimental Wistar rats. Food Sci Human Well. 2015;4:66–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.